accessibility menu, dialog, popup

UserName
Viewing profile as user:

Azo compounds

Organic compounds that contain the functional group diazenyl; diazenyl contains two nitrogen atoms bonded via a double bond in the following structure: R−N=N−R′, in which R and R′ can be an aryl or alkyl functional group.
Quantity 
  • (11)
  • (1)
  • (1)
  • (6)
  • (9)
  • (1)
  • (1)
  • (12)
  • (3)
  • (2)
  • (11)
  • (1)
  • (1)
  • (1)
  • (1)
  • (6)
  • (1)
  • (2)
  • (1)
Molecular Weight (g/mol) 
  • (3)
  • (1)
  • (1)
  • (2)
  • (2)
  • (3)
  • (1)
  • (9)
  • (2)
  • (6)
  • (1)
  • (5)
  • (1)
  • (2)
  • (1)
  • (2)
  • (2)
  • (2)
  • (2)
  • (1)
  • (2)
  • (2)
  • (1)
  • (2)
  • (2)
  • (5)
  • (1)
  • (3)
  • (2)
  • (1)
  • (1)
Physical Form 
  • (2)
  • (15)
  • (23)
  • (4)
  • (2)
  • (1)
Percent Purity 
  • (2)
  • (3)
  • (1)
  • (3)
  • (2)
  • (3)
  • (3)
  • (4)
  • (2)
  • (2)
  • (9)
  • (4)
  • (2)
  • (2)
  • (3)
  • (1)
Boiling Point 
  • (1)
  • (1)
  • (2)
  • (4)
  • (1)
  • (2)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

special offers

  • (21)

brands

  • (6)
  • (4)
  • (1)
  • (1)
  • (2)
  • (22)
  • (15)
  • (5)
  • (4)
  • (5)
  • (9)
  • (1)
  • (27)
  • (30)

special interests

  • (26)

Quantity

  • (11)
  • (1)
  • (1)
  • (6)
  • (9)
  • (1)
  • (1)
  • (12)
  • (3)
  • (2)
  • (11)
  • (1)
  • (1)
  • (1)
  • (1)
  • (6)
  • (1)
  • (2)
  • (1)

Molecular Weight (g/mol)

  • (3)
  • (1)
  • (1)
  • (2)
  • (2)
  • (3)
  • (1)
  • (9)
  • (2)
  • (6)
  • (1)
  • (5)
  • (1)
  • (2)
  • (1)
  • (2)
  • (2)
  • (2)
  • (2)
  • (1)
  • (2)
  • (2)
  • (1)
  • (2)
  • (2)
  • (5)
  • (1)
  • (3)
  • (2)
  • (1)
  • (1)

Physical Form

  • (2)
  • (15)
  • (23)
  • (4)
  • (2)
  • (1)

Percent Purity

  • (2)
  • (3)
  • (1)
  • (3)
  • (2)
  • (3)
  • (3)
  • (4)
  • (2)
  • (2)
  • (9)
  • (4)
  • (2)
  • (2)
  • (3)
  • (1)

Boiling Point

  • (1)
  • (1)
  • (2)
  • (4)
  • (1)
  • (2)

Grade

  • (1)
  • (2)

Search Within Results
Keyword Search:
76 – 90 of 109 results
76

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000370853 APG-2449 5MG

ENCOMPASS_PREFERRED
77

eMolecules​ 61551-69-7 | 2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 25g | 818522541

2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | 61551-69-7 | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 25g | 818522541

ENCOMPASS_PREFERRED
78

eMolecules​ 61551-69-7 | 2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 5g | 818522540

2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | 61551-69-7 | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 5g | 818522540

ENCOMPASS_PREFERRED
79

Apexbio Technology LLC KW 2449 1000669-72-6 10mg
SDP

KW 2449 (CAS 1000669-72-6) is a multi-targeted kinase inhibitor with potent activity against FLT3 (IC50 6 6 nM) ABL (14 nM) Aurora kinases (4 nM) and FGFR (48 nM) It inhibits both wild-type and T315I-mutated ABL tyrosine kinase In vitro KW 2449 disrupts proliferation through modulation of distinct signaling pathways it downregulates FLT3/STAT5 phosphorylation and induces G1-phase arrest and apoptosis in FLT3-mutated leukemia cells while promoting G2/M arrest via reduced histone H3 phosphorylation in FLT3 wild-type cells KW 2449 is applied in research investigating kinase-driven leukemias and resistance mechanisms to targeted therapies

ENCOMPASS_PREFERRED
80

Medchemexpress LLC CAY 10465 50mg | 688348-33-6 | 98.3% | 317.13 | 50 MG
SDP

CAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).

  • Is a selective and high-affinity AhR receptor agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM).
  • Reduces apolipoprotein A-I (apo A-I) levels in HepG2 cells, and inhibits the synthesis of the protein (0.01 nM-100 μM).

ENCOMPASS_PREFERRED
81

Apexbio Technology LLC KW 2449 1000669-72-6 10mM (in 1mL DMSO)
SDP

KW 2449 (CAS 1000669-72-6) is a multi-targeted kinase inhibitor with potent activity against FLT3 (IC50 6 6 nM) ABL (14 nM) Aurora kinases (4 nM) and FGFR (48 nM) It inhibits both wild-type and T315I-mutated ABL tyrosine kinase In vitro KW 2449 disrupts proliferation through modulation of distinct signaling pathways it downregulates FLT3/STAT5 phosphorylation and induces G1-phase arrest and apoptosis in FLT3-mutated leukemia cells while promoting G2/M arrest via reduced histone H3 phosphorylation in FLT3 wild-type cells KW 2449 is applied in research investigating kinase-driven leukemias and resistance mechanisms to targeted therapies

ENCOMPASS_PREFERRED
82

Medchemexpress LLC KW-2449 | 1000669-72-6 | 99.9% | 332.40 | 10 MG
SDP

KW-2449 is a multi-targeted kinase inhibitor that targets FLT3, ABL, ABLT315I, and Aurora kinase with IC50 values of 6.6, 14, 4, and 48 nM, respectively. It is intended for research use only.

  • Targets FLT3, ABL, ABLT315I, and Aurora kinase.
  • Exhibits antiproliferative activity against imatinib-resistant K562 cells.
  • Inhibits FLT3-mediated STAT5 phosphorylation.
  • Increases G1 phase cells and promotes apoptosis.
  • Suppresses tumor growth in FLT3-mutated xenograft models.
  • Helps release imatinib resistance.

ENCOMPASS_PREFERRED
83

Medchemexpress LLC CAY 10465 | 688348-33-6 | 98.3% | 317.13 | 100 MG
SDP

CAY 10465 is a selective and high-affinity Aryl Hydrocarbon Receptor (AhR) agonist, with a Ki of 0.2 nM. It demonstrates no effect on the estrogen receptor (Ki >100000 nM). In vitro, CAY 10465 (at concentrations from 0.01 nM to 100 μM) has been shown to reduce apolipoprotein A-I (apo A-I) levels in HepG2 cells and inhibit the synthesis of this protein.

  • Selective AhR agonist: High affinity for AhR with a Ki of 0.2 nM.
  • No estrogen receptor effect: Shows no activity on the estrogen receptor (Ki >100000 nM).
  • Inhibits apolipoprotein A-I: Reduces apo A-I levels and inhibits its synthesis in HepG2 cells.
  • Appearance: Solid, white to off-white.
  • Storage:
    Powder: -20°C for 3 years, 4°C for 2 years.
    In solvent: -80°C for 2 years, -20°C for 1 year.

ENCOMPASS_PREFERRED
84

Medchemexpress LLC CAY 10465 | 688348-33-6 | 98.3% | 317.13 | 10 MG
SDP

CAY 10465 is a selective and high-affinity AhR agonist, with a Ki of 0.2 nM, and shows no effect on estrogen receptor (Ki >100000 nM). It is intended for research use only. This compound has been shown to reduce apolipoprotein A-I (apo A-I) levels in HepG2 cells and inhibit protein synthesis.

  • Selective and high-affinity AhR agonist
  • Ki of 0.2 nM
  • No effect on estrogen receptor (Ki >100000 nM)
  • Reduces apolipoprotein A-I (apo A-I) levels in HepG2 cells
  • Inhibits protein synthesis
  • Intended for research use only

ENCOMPASS_PREFERRED
85

eMolecules​ 61551-69-7 | 2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 500g | 818522543

2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | 61551-69-7 | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 500g | 818522543

ENCOMPASS_PREFERRED
86

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000370767 APG-2449 50MG

ENCOMPASS_PREFERRED
87

Medchemexpress LLC CAY 10465 | 688348-33-6 | 98.3% | 317.13 | 1 ML
SDP

CAY 10465 is a selective and high-affinity AhR agonist with a Ki of 0.2 nM. It demonstrates no effect on the estrogen receptor (Ki >100000 nM). This compound reduces apolipoprotein A-I (apo A-I) levels in HepG2 cells and inhibits the synthesis of the protein.

  • Selective and high-affinity AhR agonist
  • No effect on estrogen receptor
  • Reduces apolipoprotein A-I levels in HepG2 cells
  • Inhibits protein synthesis

ENCOMPASS_PREFERRED
88

eMolecules​ 61551-69-7 | 2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 100g | 818522542

2,2'-Azobis[2-methyl-n-(2-hydroxyethyl)propionamide] | Combi-Blocks, Inc. | 61551-69-7 | MFCD00142728 | 288.348 | C12H24N4O4 | 98.000 | CC(C)(\N=N\C(C)(C)C(=O)NCCO)C(=O)NCCO | 100g | 818522542

ENCOMPASS_PREFERRED
89

Ambeed AMBEED

5000883023 2446-TETRABROMO-25-CYCLO 10G

ENCOMPASS_PREFERRED
90

eMolecules​ 27776-21-2 | 2,2-Azobis[2-(2-Imidazolin-2-yl)Propane] Dihydrochloride | AA Blocks LLC | MFCD00142723 | 323.270 | C12H24Cl2N6 | 0.000 | Cl.Cl.CC(C)(\N=N\C(C)(C)C1=NCCN1)C1=NCCN1 | 25g | 518488852

2,2-Azobis[2-(2-Imidazolin-2-yl)Propane] Dihydrochloride | AA Blocks LLC | 27776-21-2 | MFCD00142723 | 323.270 | C12H24Cl2N6 | 0.000 | Cl.Cl.CC(C)(\N=N\C(C)(C)C1=NCCN1)C1=NCCN1 | 25g | 518488852

ENCOMPASS_PREFERRED